Speaker
Alexander Guzzetta, MD, PhD
At the conclusion of this activity, learners should be able to:
* Incorporate clinical and morphologic findings when interpreting molecular test results
* Discuss the strengths and limitations of molecular testing in primary and metastatic thoracic malignancies
* Describe the role of pre-clinical technologies in advancing molecular diagnostics
Event Series
Current Topics in Pathology 2025